CNS Flashcards
D3 agonist
Pramipexole
Block L-dopa metabolism in CNS dopamine
Tolcapone
Antimuscarinic agents (benztropine) in Parkinsons improve symptoms except
Bradykinesia
COMT inhibitors
Entacapone
Tolcapone
TCAs
Amitriptyline
Clomipramine
Imipramine
SNRIs (Serotonin-norepinephrine reuptake inhibitors)
Venlafaxine
Desvenlafaxine
Duloxetine
Cannabinoid receptor agonist = Inverse agonist at CB1 receptors
RIMONABANT
(SE: major depression, increased suicide risk)
Treatment of obesity
Off-label use: Smoking cessation
Melatonin receptor agonist
Ramelteon
OPIOID RECEPTORS
Mu receptor = Endorphins > enkephalins > dynorphins
(Antagonist: Nalbuphine)
ENDORPHINS = Euphoria, sedation, physical dependence, tolerance
Delta receptor = Enkephalins > endorphins and dynorphins
(Antagonist: Buprenorphine)
ENKEPHALINS = antidepressant, antianxiety, decrease of colonic transit time
Kappa receptor = Dynorphins > > endorphins and enkephalins
(Antagonist: Buprenorphine – longest acting)
Elevated DYNORPHIN = increase pain/ hyperalgesia
Kappa-opioid receptor agonists = antipruritic agent
Nociceptin = structurally similar to dynorphin except for the absence of an N-terminal tyrosine; it acts only at the ORL1 receptor or NOP
NOP receptor ligands = modulation of drug reward, learning, mood, anxiety, and cough processes, and of parkinsonism
Failure to speak in full sentences; difficulty in finding words
Dysnomia
Correlate best with the severity of the dementia
Neurofibrillary tangles and quantitative neuronal loss
3 microscopic changes in Alzheimer’s
- Alzheimer neurofibrillary changes or “tangles”
- Neuritic Plaques (beta-amyloid plaque)
- Granulovacuolar degeneration of neurons
N-methyl-D-aspartate (NMDA) receptor antagonist
MEMANTINE
CHOLINESTERASE INHIBITORS used in Alzheimer’s
Donepezil
Rivastigmine
Galantamine)
HUNTINGTON DISEASE (HUNTINGTON CHOREA) - Disease triad?
Dominant inheritance
Choreoathetosis
Dementia